NEMIC Fellow Lenoss Medical Closes $6 Million Growth Bridge Financing
Founder + CEO; NEMIC Entrepreneur in Residence Dom Messerli of Lenoss
PROVIDENCE, RI - NEMIC is proud to celebrate a major milestone from within its innovation community, as NEMIC Fellow Lenoss Medical announces their successful closing of a $6 million growth bridge financing round. This achievement demonstrates both the company’s strong market trajectory and the growing momentum behind high-impact, health-focused startups emerging from the greater Rhode Island ecosystem. The financing positions Lenoss to accelerate its next phase of growth, expand operational capacity, and further validate its role as a leader in its space.
Lenoss has distinguished itself through a commitment to advancing solutions that address critical challenges in healthcare delivery and patient outcomes. As a NEMIC Fellow, the company has actively engaged in the network’s collaborative environment—leveraging connections across academia, industry, and clinical stakeholders to refine its strategy and scale its innovation. This latest round of funding reflects not only investor confidence in Lenoss’ business model, but also the strength of its leadership team and the real-world impact of its technology.
Growth bridge financing plays a pivotal role for companies at this stage—enabling them to extend runway, achieve key milestones, and position themselves for larger institutional investment or strategic partnerships. For Lenoss, this capital infusion will support continued product development, market expansion, and the deepening of partnerships that are essential to long-term success in the healthtech sector.
This milestone also speaks to the broader value of the NEMIC Fellowship model. By supporting entrepreneurs with access to strategic guidance, industry insight, and a robust network, NEMIC helps de-risk innovation and accelerate commercialization. Lenoss’ success is a clear example of how targeted support at the right moment can unlock meaningful growth and attract significant capital investment.
As Rhode Island and the surrounding region continue to strengthen their position within the national innovation landscape, moments like this matter. They demonstrate that high-potential companies can not only emerge here—but scale here. NEMIC remains committed to fostering these outcomes and looks forward to supporting Lenoss as it continues its upward trajectory.
Congratulations to the Lenoss team on this exciting achievement! We are honored to share in your success.
READ THE FULL PRESS RELEASE HERE
NEMIC + Lenoss Medical
Patented OsteoPearl technology
Dom Messerli joined NEMIC as our first-ever co-worker in 2018. He quickly became a massive asset to the ecosystem due to his extensive domain knowledge, and his background as the director of product development at DePuy Synthes—the orthopedic arm of Johnson & Johnson. Messerli’s introduction to NEMIC came when he enrolled as a student in the inaugural year of our Med Tech Leadership Program—NEMIC’s signature education course. Messerli was able to fill in the missing pieces of Lenoss Medical’s business plan and was soon accepted into the NEMIC’s Activate Program. This accelerator, supported by Rhode Island Commerce, awarded Messerli with $20,000 in funds to support the setup of Lenoss’ clinical trial site.
Lenoss Medical successfully raised funds of $200,000 as a direct result of the milestones achieved through NEMIC programming. The startup has since raised a total of $2.5 million from regional venture capital groups, including the Slater Technology Fund, Cherrystone Angel Group, MagpieX Med Tech Ventures, Walnut Ventures, Beacon Angels, River Valley Investors, and Mr. Hansjörg Wyss. In 2023, Lenoss was awarded more than $49,000 via an Innovation Voucher funded by Rhode Island Commerce.
Dom Messerli continues to lead Lenoss Medical within the NEMIC’s co-working space, where he is a valued asset to the Med Tech community. He has hired several independent contractors, as well as FTE staff members to his team. Today, Messerli is one of many expert instructors in the Med Tech Leadership Program, where he teaches Due Diligence 101 to new cohorts of aspiring entrepreneurs and industry professionals.
